What alternative medication can be used instead of ceftriaxone (Rocephin) for treating gonorrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Medications for Gonorrhea When Ceftriaxone Is Unavailable

If ceftriaxone is unavailable, use cefixime 400 mg orally plus azithromycin 1 g orally as a single dose, with mandatory test-of-cure at 1 week. 1

First-Line Alternative: Oral Cefixime

Cefixime 400 mg orally plus azithromycin 1 g orally (both single dose) is the CDC-recommended alternative when ceftriaxone cannot be obtained. 1, 2

Efficacy by Anatomic Site

  • Cefixime achieves 97.4% cure for urogenital infections and 97% cure for rectal infections, but only 78.9–89% cure for pharyngeal infections—significantly lower than ceftriaxone's 99% rate. 1, 3
  • The reduced pharyngeal efficacy is critical because pharyngeal gonorrhea is a key site for antimicrobial resistance emergence and can persist asymptomatically for up to 16 weeks. 4
  • Cefixime provides lower and less sustained bactericidal levels than ceftriaxone, explaining its reduced overall effectiveness. 1

Mandatory Follow-Up

  • Test-of-cure is required at 1 week (7 days post-treatment) for all cefixime-treated patients due to rising minimum inhibitory concentrations and declining effectiveness. 1
  • Use culture (preferred, allows susceptibility testing) or nucleic acid amplification test if culture unavailable; if NAAT positive, confirm with culture and perform antimicrobial susceptibility testing. 1

Severe Cephalosporin Allergy Options

Azithromycin Monotherapy

For patients with documented severe cephalosporin allergy, azithromycin 2 g orally as a single dose is an option, but has only 93% efficacy and high gastrointestinal side effects. 1, 5

  • Mandatory test-of-cure at 1 week is required. 5
  • This regimen should never be used as routine therapy due to lower efficacy and risk of rapid resistance emergence. 1
  • Azithromycin resistance ranges from 4–7% in North America but can reach 66% in East Asian regions. 1

Gentamicin Plus Azithromycin

Gentamicin 240 mg IM plus azithromycin 2 g orally (single dose) achieved 100% microbiological cure in clinical trials but has poor pharyngeal efficacy. 1, 6

  • A large randomized controlled trial found gentamicin cleared only 80% of pharyngeal infections versus 96% for ceftriaxone, and 90% of rectal infections versus 98% for ceftriaxone. 7
  • One study was stopped early because only 2 of 10 individuals with pharyngeal gonorrhea treated with gentamicin were cured (20% efficacy). 4, 1
  • Gentamicin causes significantly more injection site pain than ceftriaxone. 7
  • This regimen should only be used when azithromycin susceptibility is confirmed, particularly in regions with high azithromycin resistance. 1

Spectinomycin

Spectinomycin 2 g IM achieves 98.2% cure for urogenital and anorectal infections but only 52% cure for pharyngeal infections. 4, 1, 2

  • Spectinomycin should be avoided when pharyngeal exposure is possible or suspected. 1
  • For pregnant patients with severe cephalosporin allergy, spectinomycin 2 g IM plus azithromycin 1 g orally is acceptable, though pharyngeal efficacy remains poor. 1

Other Alternative Cephalosporins (When Ceftriaxone Unavailable)

The following injectable cephalosporins are effective but offer no advantage over ceftriaxone: 4, 2

  • Ceftizoxime 500 mg IM (single dose)
  • Cefoxitin 2 g IM with probenecid 1 g orally (single dose)
  • Cefotaxime 500 mg IM (single dose)

Contraindicated Medications

Fluoroquinolones

Fluoroquinolones (ciprofloxacin, ofloxacin, levofloxacin) are absolutely contraindicated for gonorrhea treatment due to widespread resistance, despite historical cure rates exceeding 99%. 1, 8

  • Quinolones should never be used, even if susceptibility testing suggests activity, because resistance patterns have rendered them universally ineffective. 1
  • Quinolones are also contraindicated in individuals ≤17 years of age and during pregnancy. 1

Azithromycin Monotherapy

Azithromycin 1 g alone should never be used for gonorrhea treatment—it achieves only 93% efficacy and risks rapid resistance emergence. 1

Treatment Failure Management

If treatment failure is suspected: 1, 5

  • Obtain specimens from all potentially infected sites for culture with antimicrobial susceptibility testing immediately
  • Report the case to local public health officials within 24 hours
  • Consult an infectious disease specialist
  • Recommended salvage regimens include:
    • Gentamicin 240 mg IM plus azithromycin 2 g orally (if azithromycin-susceptible)
    • Ertapenem 1 g IM for 3 days 4, 1

Special Populations

Pregnancy

  • Pregnant patients should receive ceftriaxone 500 mg IM plus azithromycin 1 g orally. 1
  • Never use quinolones, tetracyclines, or doxycycline in pregnancy due to fetal safety concerns. 1, 5
  • If severe cephalosporin allergy exists, use spectinomycin 2 g IM plus azithromycin 1 g orally. 1

Men Who Have Sex with Men

  • Ceftriaxone is the only recommended treatment for MSM due to higher prevalence of resistant strains; quinolones must never be used in this population. 1

Critical Partner Management

  • All sexual partners from the preceding 60 days must be evaluated and treated with the same dual therapy regimen, regardless of symptoms or test results. 1, 5
  • Partners should receive ceftriaxone 500 mg IM plus azithromycin 1 g orally, or cefixime 400 mg plus azithromycin 1 g orally if ceftriaxone unavailable. 1
  • Patients must abstain from sexual intercourse until therapy is completed and both patient and all partners are asymptomatic. 1

Common Pitfalls to Avoid

  • Never assume oral cephalosporins are equivalent to ceftriaxone—they have inferior efficacy, especially for pharyngeal infections. 1
  • Never omit test-of-cure when using alternative regimens—it is mandatory for cefixime and azithromycin monotherapy. 1
  • Never use gentamicin or spectinomycin for suspected pharyngeal gonorrhea—both have unacceptably low cure rates at this site. 4, 1
  • Never use cefixime as monotherapy without azithromycin—this violates CDC dual therapy recommendations. 1

References

Guideline

Gonorrhea Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Alternative Treatment Options for Gonorrhea and Chlamydia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Gonorrhea in Patients Allergic to Ceftriaxone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.